AI assistant
Sending…
Minerva Neurosciences, Inc. — Director's Dealing 2025
Dec 23, 2025
35086_dirs_2025-12-23_58ffd3a6-f6b6-4a68-b4ae-7d4a68e90a5e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2025-12-22
Reporting Person: Race Geoff (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-12-22 | Employee Stock Option (right to buy) | $3.98 | A | 1500000 | Acquired | 2035-12-21 | Common Stock (1500000) | Direct |
Footnotes
F1: The option vests 25% on December 22, 2026 and then in equal quarterly installments over 3 years thereafter.
More from Minerva Neurosciences, Inc.
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 6
Regulatory Filings
2026
Mar 20
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 12
Major Shareholding Notification
2026
Feb 5